Detalles de la búsqueda
1.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
N Engl J Med
; 387(8): 692-703, 2022 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35833805
2.
DEFINING "STRONG" VERSUS "WEAK" RESPONSE TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR CENTER-INVOLVED DIABETIC MACULAR EDEMA.
Retina
; 43(4): 616-623, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728692
3.
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results.
Ophthalmology
; 127(4S): S135-S145, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32200813
4.
Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 40.
Ophthalmology
; 127(6): 784-792, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31899035
5.
Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration.
Ophthalmology
; 126(6): 856-865, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30278196
6.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
N Engl J Med
; 372(13): 1193-203, 2015 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25692915
7.
Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Ophthalmology
; 125(7): 1037-1046, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29454660
8.
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Ophthalmology
; 125(12): 1913-1928, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30060980
9.
Decreased Visual Function Scores on a Low Luminance Questionnaire Is Associated with Impaired Dark Adaptation.
Ophthalmology
; 124(9): 1332-1339, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28602520
10.
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
Ophthalmology
; 123(8): 1751-1761, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27156698
11.
Longitudinal Study of Age-Related Cataract Using Dynamic Light Scattering: Loss of α-Crystallin Leads to Nuclear Cataract Development.
Ophthalmology
; 123(2): 248-254, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26545319
12.
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
Ophthalmology
; 123(6): 1351-9, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26935357
13.
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.
Ophthalmology
; 123(4): 841-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26875003
14.
The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.
Ophthalmology
; 122(12): 2490-6, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26435335
15.
Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT).
Ophthalmology
; 122(12): 2523-31.e1, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26383996
16.
Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen.
Ophthalmology
; 122(10): 2053-62, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26253372
17.
The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.
Ophthalmology
; 122(7): 1471-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25972257
18.
Changes in lens opacities on the age-related eye disease study grading scale predict progression to cataract surgery and vision loss: age-related eye disease study report no. 34.
Ophthalmology
; 122(5): 888-96, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25682177
19.
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).
Ophthalmology
; 122(2): 391-398.e5, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25307130
20.
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
JAMA
; 314(20): 2137-2146, 2015 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26565927